Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02623803 · ClinicalTrials.gov registry record · Phase 4
Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT02623803: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT02623803 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02623803, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if a lidocaine infusion will provide benefit to pancreatectomy patients in regards to analgesia and return of bowel function.
Interventions
- DRUG Lidocaine
- DRUG Placebo D5W
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02623803
The ClinicalTrials.gov registry entry for NCT02623803 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine is the first listed.
NCT02623803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02623803 about?
NCT02623803 is a clinical study titled "Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies". The purpose of this study is to evaluate if a lidocaine infusion will provide benefit to pancreatectomy patients in regards to analgesia and return of bowel function.
What is the current status of trial NCT02623803?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2016-01. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02623803?
The interventions under investigation include: Lidocaine (DRUG), Placebo D5W (DRUG).
Who is sponsoring clinical trial NCT02623803?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.